08 June 2021

safety alerts

Reference: CIR-2021-00000086

To all health facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the Circular issued by the MOHAP for perusal and adhere to what is stated

 

Recall & Suspension of registration for Pharmaceutical Product Omiz Plus 20mg Capsule / Omiz Plus 40mg Capsule

Voluntary recall of certain lots of contact lens solutions, eye wash and eye lubricants 

 

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

تعميم - سحب وتعليق Omiz Plus 20 40mg Capsule.pdf:

View Document

تقارير السلامة - محاليل العدسات اللاصقة.pdf:

View Document